The Myriad gene patents case will be heard by the US Supreme Court. That is good news, I think. The whole area of gene patents is murky as a matter of law and legal principle.
My report on the original case can be found here. However, that judgment was overturned on appeal. In my view, the original judgment had a great deal of merit. In any event, the issue is overdue for consideration by a national court at the highest level. I hope we get a clear, principled decision out of this, however the court views it.